4//SEC Filing
Meyers Michael L. 4
Accession 0001562180-19-002012
CIK 0001395937other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:05 PM ET
Size
6.2 KB
Accession
0001562180-19-002012
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2019-03-21$4.93/sh+1,000$4,930→ 7,118 total - Purchase
Common Stock
2019-03-21$4.87/sh+104$506→ 7,222 total
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:05 PM ET
- Size
- 6.2 KB